Tag: ENTA

Company

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Down Almost -30.84% In 1 Month, Long Term Looking Good As Well

In last trading session, Enanta Pharmaceuticals Inc (NASDAQ:ENTA) saw 0.65 million shares changing hands with its beta currently measuring 0.56. Company’s recent per share price

Company

Is Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Still A Buy After sinking -17.94% Last Week?

During the last session, Enanta Pharmaceuticals Inc (NASDAQ:ENTA)’s traded shares were 1.02 million, with the beta value of the company hitting 0.49. At the end

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: ENTA

Enanta Pharmaceuticals Inc (NASDAQ:ENTA) Down Almost -30.84% In 1 Month, Long Term Looking Good As Well

Is Enanta Pharmaceuticals Inc (NASDAQ: ENTA) Still A Buy After sinking -17.94% Last Week?

Quick Links

Categories